Manufacture of Medical Heat Treatment Pads

The contract involves the full-scale production of single-use medical heat treatment pads designed to activate at room temperature and consistently reach a precise temperature of 112°F (44°C), ensuring therapeutic efficacy while adhering to stringent military and medical safety standards. The production must meet exacting quality and performance benchmarks to ensure reliability in field and clinical environments, with all units required to be compliant with regulatory and operational requirements for use by defense and healthcare personnel. The work is classified as a subcontract under NAICS code 325412, indicating the manufacturing of pharmaceutical and biological products, with performance expected at Williamsburg, Virginia, 23185-5830. The solicitation was posted on August 9, 2026, with a firm response deadline of August 17, 2026, and is issued under the Department of Defense through the Medical Supply Chain FSH organization. While no formal set-aside criteria are specified, the procurement is part of a broader effort to secure a dependable, scalable supply of advanced thermal medical devices for military and medical applications. The contract is managed under a DIBBS platform listing, and all submissions must comply with the technical, operational, and logistical demands outlined by the procuring agency to ensure seamless integration into existing supply chains and deployment protocols.